Search
Showing results for "early lung health"
A new study has found a common asthma drug is effective for some very premature babies who go on to suffer from lung complications.
This review aims to summarise what is known about the long-term pulmonary outcomes of contemporary preterm birth
Every child deserves the best possible start in life. Evidence demonstrates the period from pre-birth to three years is a vital period of development. It lays the foundations for a child’s future and has life-long impacts on health, education, job opportunities, social inclusion and wellbeing.
Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis Early diagnosis and treatment in
Better understanding of evolution of lung function in infants with cystic fibrosis...
Researchers from the Telethon Institute have today been awarded $3.46 million in competitive grants and two early career fellowships from the NHMRC.
This large population-based study suggests a significant healthcare burden associated with influenza in children with a range of chronic lung diseases
Children’s interstitial and diffuse lung disease (chILD) is a complex heterogeneous group of lung disorders. Gene panel approaches have a reported diagnostic yield of ~ 12%. No data currently exist using trio exome sequencing as the standard diagnostic modality.
The Early Moves study is investigating whether a baby’s early movements can predict learning difficulties later in childhood.
The Early Years Systems Evidence (EYSE) team specialises in working in partnership with governments and service providers, with a distinct focus on improving the life chances of children in Australia.